A Very Early Rehabilitation Trial (AVERT): a prospective phase 3, multicentre, randomised controlled trial of efficacy (death and disability at 3 months) and cost-effectiveness of very early rehabilitation (early and more frequent rehabilitation sessions) versus standard care (the rehabilitation care a patient would normally receive) in patients with acute stroke

HS Greater Glasgow and Clyde (UK)0 个研究点目标入组 2,104 人开始时间: 2014年3月12日最近更新: 2016年11月7日

适应症

试验速览

暂无简介。

•1. Pre stroke mRS of 3, 4 or 5 (previous significant disability)
•2. Deterioration in patients condition in the first hour resulting in admission to ICU, surgery or documented palliative treatment.
•3. Concurrent diagnosis of rapidly deteriorating disease.
•4. Unstable coronary or other medical condition which is judged by the investigator to pose a hazard to the patient by involvement in the trial.
•5. A confirmed or suspected lower limb fracture preventing implementation of the protocol tPA. Patients can be included if the treating physician permits and mobilisation within 24 hours is permitted.
•6. Patients cannot be concurrently recruited to drug or other intervention trials.
•7. Vital signs not within protocol specified normal limits.

发起方

HS Greater Glasgow and Clyde (UK)